The complete 104-event history

A widely anticipated annual cut produced little incremental downside after a severe year-to-date derating.

A real second-quarter growth beat, record backlog and above-plan margin were partly offset by weak cash conversion.

A broad Q2 acceleration drove a top-line and EBITDA beat, but management paired a higher local-currency sales range with a lower percentage-margin range while protecting the absolute EBITDA outlook.

Churn-led subscriber growth, record margins and a broad operating-guidance increase turned the turnaround into a multi-quarter operating trend.

Record AI and cloud orders were offset by an optical sales miss, weak cash flow and a Q3 profit guide well below consensus; the annual raise was accounting-driven.

A strong reported quarter failed to clear the forward bar because only cash-flow guidance increased and the Q3 setup looked softer than expected.

The deepest guidance cut of the cycle drove an initial drop, but low expectations and stronger organic growth limited the damage.

The headline beat was overwhelmed by a bioprocessing miss and a guidance cut in the segment investors trusted most.

Record awards and backlog supported the demand thesis, but program charges and a tax-driven EPS raise left underlying margin progress limited.

An 88% revenue increase, record AI and traditional-server demand, and a $27B full-year revenue raise produced a second thesis-changing quarter.

A record backlog and higher annual revenue outlook outweighed an in-quarter margin miss.

Near-100% capture through heavy maintenance and a new $5B buyback authorization created a strong operational signal, partly offset by a midstream miss.

An anticipated, currency-composed beat did little on day one, but excluded helium and volume upside supported the later recovery.

A conservative second-quarter growth signpost reset expectations after a strong run in the shares.

Strong account growth, ARPA, EBITDA and cash flow countered structural-competition fears and produced a relief rally.

The first positive first-quarter phone result since 2013 and an EPS raise extended the turnaround despite weak revenue and ARPA.

A major Network Infrastructure and optical growth raise made the AI thesis tangible, while the formal group-profit range stayed unchanged.

A feared guidance cut de-risked the year and produced a relief rally, but WATCHMAN weakness made the recovery fragile.

Revenue growth did not protect the stock when Service margin missed the level needed for the second-half plan.

A beat-and-raise strengthened the recovery case, but the flow-through was incomplete and respiratory assumptions became less secure.

Aeronautics growth and B-21 capacity funding strengthened long-term demand, but a Space charge, higher capex and withdrawal of the 2028 FCF target drove a sharp selloff.

Organic growth and Asia materially exceeded a depressed consensus while full-year sales and margin guidance remained intact, easing fears that the earnings-cut cycle had further to run.

Record AI orders and a FY2027 outlook far above consensus reframed Dell as an AI-infrastructure compounder despite a demanding pricing and margin bridge.

A flat top line concealed stronger cash, a larger dividend and a longer margin runway.

Strong free cash flow and savings delivery provided a floor, while a weak China exit and 1–4% 2026 sales guide confirmed the lower-growth regime.

Soft phone additions and churn were offset by broadband strength and a Capital Markets Day framework that reaccelerated the medium-term earnings story.

A cleaner exit rate and initial 2026 framework suggested the long-awaited volume recovery was becoming plausible.

Flat sequential US electrophysiology performance crystallized the share-loss fear embedded in a premium multiple.

A supply-constrained FY2027 AI marker turned an in-line quarter into a structural growth event.

Exceptional capture and record throughput outweighed a larger 2026 capital program and a deliberately weak first-quarter operating setup.

A huge subscriber beat, aggressive 2026 volume guide and first major buyback authorization overwhelmed weak service-revenue and EBITDA quality.

Cloud and optical momentum broadened the thesis, while a below-consensus 2026 profit midpoint and Network Infrastructure growth guide drove an initial selloff.

A largely preannounced quarter and a prudent 2026 framework offered no incremental catalyst to a crowded position.

A below-consensus 2026 earnings framework confirmed that the recovery would be back-end loaded and margin constrained.

Double-digit Q4 sales growth and a record backlog supported the production thesis, while a below-consensus 2026 EPS guide, higher capex and buyback pause restrained upside.

Record AI orders and a $18.4B backlog supported a large Q4 and full-year raise, though the initial rally faded as investors debated supply and margins.

A large increase in the AI data-center power target reframed the stock from auto-cycle recovery to structural AI growth.

A modest EPS miss and weaker capture broke MPC's long beat streak, but rising cracks and cleaner maintenance later overwhelmed the initial disappointment.

A tax-driven earnings beat could not offset helium and volume weakness or a below-consensus fourth-quarter guide.

Service and modernization reaccelerated, repairing part of the prior-quarter credibility gap.

Near-breakeven consumer phone performance and disciplined new-CEO messaging cleared a heavily de-risked bar despite a revenue miss.

A small, anticipated sales beat lacked a fresh catalyst against a rich valuation and weak sector tape.

A cut to the Strategy 2028 growth algorithm and weak APAC organic sales transformed a cyclical slowdown into a more structural de-rating debate.

Optical growth and margin improvement strengthened the operating story, but the formal profit raise came from venture-fund reclassification rather than better operations.

Record subscriber performance could not overcome concerns that the guidance raise contained too little underlying profitability.

WATCHMAN acceleration and an above-Street fourth-quarter guide provided relief, but a narrower electrophysiology surprise capped the move.

Management removed a major 2026 overhang by framing a credible earnings algorithm on modest core growth.

Strong Mission and Defense margins lifted EPS, but a revenue miss and full-year sales cut showed backlog conversion remained uneven.

Dell lifted its AI, revenue and EPS outlook after an $8.2B AI shipment quarter, but gross-margin dilution and a soft Q3 EPS guide dominated the reaction.

Profitability improved before revenue, validating self-help and mix while foreign exchange masked underlying volume.

Triple-digit capture and high utilization produced a clear earnings beat, but lower Q3 runs, higher turnaround cost and slower buybacks tempered the reaction.

Another small beat extended the quality streak, but currency—not demand—funded the guidance improvement.

Margin resilience won the half-year debate, but the absence of a volume inflection prevented a re-rating.

Sika cut its growth outlook after weak organic demand and FX, while holding the EBITDA-margin range through higher MBCC synergies and self-help.

A fully explained FX-and-tariff guidance cut and weak Mobile Networks result triggered a sharp initial fall, then recovered as the operational thesis remained intact.

A broad beat and a guidance increase larger than the quarterly surprise reinforced estimate momentum.

A broad organic-sales downgrade and further Service slippage converted a defensive compounder into a show-me story.

A large subscriber beat and raised customer outlook repaired the guidance credibility lost in Q1.

The quarter cleared the three largest fears: bioprocessing growth, China procurement pressure and margin conversion.

A clean B-21 quarter, Defense Systems strength and an FCF raise drove a sharp relief rally, although tax and divestiture benefits lowered earnings quality.

Higher cash guidance and better consumer losses produced a relief rally, but the underlying volume and broadband story remained weak.

Record AI orders and backlog strengthened the demand thesis, but EPS, recognized AI revenue and gross margin disappointed, producing a muted reaction.

Investors treated the guidance reduction as foreign-exchange and tariff prudence rather than new demand weakness.

Refining and midstream both beat in a heavy-maintenance quarter, but a slightly light Q2 throughput guide and rising net debt limited the rerating.

A tax-aided beat and held annual midpoint delivered exactly the de-risked cadence investors expected.

Resilient sales, a record backlog and improving March activity supported the margin thesis without proving a volume recovery.

A €120M Mobile Networks settlement drove a major profit decline, while optical growth and an unchanged annual range kept the medium-term recovery alive.

A tiny miss on the most highly valued operating KPI broke the beat-and-raise narrative despite strong EBITDA and free cash flow.

Boston Scientific raised growth through a tariff shock, reinforcing the resilience premium.

The first crack in the Service flywheel mattered more than a headline earnings beat.

A clean beat against a de-risked bar confirmed bioprocessing stabilization and protected the earnings floor.

A $477M B-21 charge and a large sales miss reopened the program-risk thesis even as annual sales and cash guidance remained intact.

Record EBITDA and strong free cash flow offset an unusually poor consumer-phone quarter, leaving the stock close to flat.

Modest organic growth and strong Americas performance kept guidance intact, but weak Asia and a sales-only disclosure offered little proof of margin conversion.

A profitability beat was overshadowed by falling AI shipments, a soft Q1 guide and an FY2026 margin framework that made the earnings path more demanding.

A record year extended the margin ambition and confirmed that pricing, efficiency and backlog could offset weak volumes.

Record EBITDA and margin confirmed synergy delivery, while the first 2025 guide of 3–6% local-currency growth reset the market below the old 6–9% algorithm.

Margin execution offset another soft volume quarter, while the initial 2025 framework preserved a cautious earnings path.

A clean beat and above-consensus 2025 growth plan validated the operating story but produced only modest upside at a high multiple.

A mostly currency-funded guidance raise was interpreted as evidence that the down-cycle had stopped worsening.

A 119% capture rate and strong EBITDA produced a large beat, while the market looked through a deliberately weak Q1 maintenance quarter.

A record $91.5B backlog and absence of new B-21 or Sentinel charges underpinned a stable 2025 outlook, though the reaction remained muted.

A double-digit sales rebound and licensing upside restored earnings momentum, while the 2025 profit midpoint below consensus capped the rerating.

A better fourth quarter closed a down year, but the initial 2025 plan embedded a soft first quarter and only modest full-year recovery.

The first 2025 earnings guide screened below consensus, but investors treated most of the gap as foreign exchange.

A solid quarterly beat was overshadowed positively by the highest-ever opening customer guide and an upgraded service-revenue outlook.

The best consumer phone quarter since 2021 outweighed a modest EBITDA miss, but light initial FCF guidance capped enthusiasm.

Improving ISG margin could not offset delayed Blackwell shipments, weak consumer PCs and a Q4 revenue guide nearly $1B below consensus.

A sharp first-quarter revenue step-down and weak margin framework reset expectations below an already reduced bar.

Better throughput and capture plus a new $5B buyback authorization drove a durable positive reaction despite a soft Q4 operating guide.

The first downward guidance change in years broke the expected beat-and-raise pattern.

A modest earnings miss became more important when China forced cuts to sales, cash flow and the forward margin base.

Local-currency growth accelerated and EBITDA margin expanded sharply, validating the MBCC synergy bridge despite a still-mixed construction backdrop.

Solid EPS and backlog growth were offset by a revenue miss, Defense Systems timing and a lower Mission Systems margin outlook.

At a sales-only update, a new margin signpost and record investment decisions mattered more than an in-line top line.

A broad beat-and-raise was temporarily obscured by a clinical-trial pause unrelated to commercial demand.

Subscriber leadership, ARPA acceleration and a large free-cash-flow beat validated the premium growth model, but much of the good news was already embedded in valuation.

The beat was discounted because its mix pulled demand forward and the unchanged annual plan implied a weak finish.

Routine EBITDA and cash beats were overwhelmed by a higher 2025 capex plan and uncertainty over free cash flow.

A broad sales shortfall and Mobile Networks decline challenged the recovery thesis, but gross margin and Network Infrastructure resilience prevented a lasting selloff.

A large AI-server and EPS beat established Dell as an AI share gainer, while a soft Q3 EPS guide and delayed PC refresh limited follow-through.

Exceptionally strong capture and cash returns outweighed a seasonally lower Q3 utilization guide, but the first-day rally did not survive the next quarter.

A modest bottoming signal was overwhelmed by a global risk-off shock and a worsening automotive demand narrative.

A pricing-led quality beat reinforced Linde's defensive value during a broad market selloff.